Journal Name: Journal of Blood Disorders and Malignancies
ISSN:
DOI: 10.31021
Journal Type: Open Access
Contact Us: Click Here
Yusheng Zhu
Professor,United States
Eva Segelov
Professor,Australia
Alexander Birbrair
Professor,Brazil
Ewelina Grywalska
Assoc. Professor,Poland
Masood A. Shammas
Scientist,United States
Lívia Dickson Chen
Scientist,Brazil
Anil Tombak
Assoc. Professor,Turkey
Md. Sohrab Hossain
Adjunct Assistant Professor,United States
Mousa Ahmad Sulieman Qatawneh
Senior Specialist at Royal Medical Services,Jordan
The Journal of Blood Disorders and Malignancies is an authoritative source for the latest research and developments in the field of hematology. Our journal is committed to advancing the understanding, diagnosis, treatment, and prevention of blood disorders and hematologic malignancies. We serve as a vital resource for clinicians, researchers, and healthcare professionals dedicated to improving patient outcomes in this critical area of medicine.
Our mission is to enhance the scientific and clinical understanding of blood disorders and malignancies by providing a platform for high-quality, peer-reviewed research. We aim to facilitate the translation of basic research findings into clinical applications, ultimately improving patient care and outcomes.
The Journal of Blood Disorders and Malignancies covers a broad spectrum of topics within hematology, including but not limited to:
Hematologic Malignancies: Research on leukemia, lymphoma, myeloma, and other blood cancers, including their pathophysiology, diagnosis, and treatment.
Non-Malignant Blood Disorders: Studies on anemia, thrombocytopenia, hemophilia, and other non-malignant blood disorders, focusing on their underlying mechanisms and therapeutic approaches.
Stem Cell and Bone Marrow Transplantation: Advances in stem cell biology, transplantation techniques, and post-transplant care for patients with blood disorders and malignancies.
Hematopoiesis and Blood Cell Function: Insights into the processes of blood cell formation and function, including the regulation of hematopoiesis and the role of different blood cell types.
Coagulation and Hemostasis: Research on the mechanisms of blood clotting, bleeding disorders, and the development of anticoagulant therapies.
Genetics and Genomics: Studies on the genetic and genomic alterations associated with blood disorders and malignancies, including their implications for diagnosis and treatment.
Innovative Therapies: Exploration of new and emerging therapies, including targeted treatments, immunotherapies, and personalized medicine approaches.
Clinical Trials and Case Studies: Reports on clinical trials, novel treatment protocols, and case studies that provide insights into the practical application of research findings.
We invite researchers, clinicians, and healthcare professionals to join our community. Stay informed about the latest advancements in hematology, share your research, and collaborate with peers to drive innovation and improve patient care in the field of blood disorders and malignancies.
The Journal of Blood Disorders and Malignancies welcomes submissions of original research articles, review papers, case reports, and clinical studies that contribute to the understanding and treatment of blood disorders and hematologic malignancies. Share your findings with a global audience and help advance the field of hematology.
Thank you for choosing the Journal of Blood Disorders and Malignancies as your trusted source for the latest research and developments in hematology. Together, we can make significant progress in the diagnosis, treatment, and prevention of blood disorders and malignancies, ultimately improving patient outcomes and quality of life.
Advancing Scientific Knowledge: Our aim is to publish high-quality, peer-reviewed research that enhances the understanding of blood disorders and malignancies, contributing to scientific advancements and clinical practice.
Improving Clinical Outcomes: We strive to support the translation of research findings into clinical applications, thereby improving the diagnosis, treatment, and management of patients with hematologic conditions.
Facilitating Interdisciplinary Collaboration: We aim to foster collaboration among researchers, clinicians, and healthcare professionals across various disciplines to address the complex challenges associated with blood disorders and malignancies.
Promoting Innovation: Our goal is to highlight innovative research and emerging therapies that have the potential to revolutionize the field of hematology and improve patient care.
The scope of the Journal of Blood Disorders and Malignancies includes a wide range of topics related to hematology, such as:
Hematologic Malignancies: Leukemia, lymphoma, myeloma, and other blood cancers, including their pathophysiology, genetic and molecular basis, diagnostic techniques, and treatment options.
Non-Malignant Hematology: Disorders such as anemia, thrombocytopenia, hemophilia, sickle cell disease, and other non-malignant blood conditions, with a focus on their underlying mechanisms and therapeutic strategies.
Stem Cell Research and Transplantation: Innovations in stem cell biology, bone marrow transplantation, and cellular therapies, including techniques to enhance engraftment and reduce transplant-related complications.
Blood Cell Development and Function: Research on the biology of hematopoiesis, the regulation of blood cell development, and the functional roles of different blood cell types in health and disease.
Coagulation and Bleeding Disorders: Studies on the mechanisms of coagulation, the pathophysiology of bleeding disorders, and the development of new anticoagulant and hemostatic agents.
Genetic and Genomic Research: Investigations into the genetic and genomic alterations that contribute to blood disorders and malignancies, including their implications for personalized medicine and targeted therapies.
Clinical and Translational Research: Clinical trials, case reports, and translational studies that bridge the gap between laboratory research and clinical practice, highlighting new treatment protocols and patient management strategies.
Through our comprehensive aims and scope, the Journal of Blood Disorders and Malignancies seeks to be a leading resource for the latest research, clinical practices, and educational advancements in the field of hematology.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Send Information
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org
Copyright © 2020 Boffin Access Limited.
